Home > News > Final Report Confirms BrachySil Safe and Well Tolerated
June 21st, 2005
Final Report Confirms BrachySil Safe and Well Tolerated
Abstract:
Global nanotechnology company pSivida Limited and the Singapore General Hospital, today announced key findings from the final report on its Phase IIa clinical trials with BrachySil(TM) as a potential new brachytherapy treatment for inoperable primary liver cancer.
Source:
businesswire
Related News Press |
Possible Futures
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
Nanomedicine
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
SMART researchers pioneer first-of-its-kind nanosensor for real-time iron detection in plants February 28th, 2025
Announcements
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |